RxDoctor Payments DataLook up a doctor →

Mark Goldstein

Neurology · Atlantis, FLNPI 1013952282

Payments from drug & device makers

$36,072,352in general payments, 2019–2025

Across 1,216 payments — averaging $29,665 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$15.5M
  • Biogen$7.5M
  • Genentech, Inc.$5.5M
  • Eisai Inc.$3.5M
  • Novartis$1.7M
  • UCB SA$806K
  • plus $1.6M from 17 others
$223,214in research payments, 2019–2025

Across 10 payments — averaging $22,321 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$223K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$36,072,352 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida

Other neurology in Atlantis

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →